Product NDC: | 63739-516 |
Proprietary Name: | Lamotrigine |
Non Proprietary Name: | Lamotrigine |
Active Ingredient(s): | 100 mg/1 & nbsp; Lamotrigine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-516 |
Labeler Name: | McKesson Packaging Services a buisness unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090607 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110608 |
Package NDC: | 63739-516-10 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-516-10) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 63739-516-10 |
Proprietary Name | Lamotrigine |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-516-10) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 63739-516 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lamotrigine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110608 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services a buisness unit of McKesson Corporation |
Substance Name | LAMOTRIGINE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |